PDSBVSVBIO• 12 Months (Normalized)
PDSB vs VBIO (PDS Biotechnology Corporation vs Valion Bio Inc.)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PDSB Performance $0.59
-49.57%
PDS Biotechnology Corporation
Normalized Baseline0.00%
VBIO Performance $2.11
-97.22%
Valion Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin PDSB LEADS
+47.65%
PDSB outperforming by 47.65%
PDSBVBIO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PDSB VBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | PDSB Price | PDSB Gain (%) | VBIO Price | VBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.59 | -49.57% | $2.11 | -97.22% | +47.65% |
| Sep 14, 2026 | $0.40 | -65.60% | $2.10 | -97.24% | +31.64% |
| Sep 11, 2026 | $0.30 | -74.57% | $2.26 | -97.03% | +22.46% |
| Sep 10, 2026 | $0.32 | -72.84% | $2.20 | -97.11% | +24.27% |
| Sep 09, 2026 | $0.29 | -74.74% | $2.40 | -96.84% | +22.10% |
| Sep 08, 2026 | $0.30 | -74.14% | $2.50 | -96.71% | +22.57% |
| Sep 04, 2026 | $0.22 | -81.03% | $2.77 | -96.36% | +15.33% |
| Sep 03, 2026 | $0.22 | -81.03% | $2.80 | -96.32% | +15.29% |
| Sep 02, 2026 | $0.21 | -81.72% | $3.12 | -95.89% | +14.17% |
| Sep 01, 2026 | $0.20 | -82.41% | $3.07 | -95.96% | +13.55% |
| Aug 31, 2026 | $0.21 | -81.55% | $3.57 | -95.30% | +13.75% |
| Aug 28, 2026 | $0.21 | -81.81% | $3.03 | -96.02% | +14.21% |
| Aug 27, 2026 | $0.22 | -81.21% | $3.08 | -95.95% | +14.74% |
| Aug 26, 2026 | $0.22 | -80.78% | $3.90 | -94.87% | +14.09% |
| Aug 25, 2026 | $0.22 | -80.86% | $3.98 | -94.77% | +13.91% |
Page 1 of 17